Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 384 Issue 6604, 7 November 1996

Opinion

  • As it struggles to overcome the legacy of apartheid, South Africa needs to protect and strengthen the most productive parts of its science base. That requires a tough approach to the redistribution of resources – and determination to tackle big spenders.

    Opinion

    Advertisement

  • Despite an out-of-court settlement last week, science must not rely on litigation to keep its house in order.

    Opinion
Top of page ⤴

News

Top of page ⤴

News in Brief

Top of page ⤴

Briefing

Top of page ⤴

Correspondence

Top of page ⤴

News & Views

Top of page ⤴

Scientific Correspondence

Top of page ⤴

Book Review

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Collection

  • Developments in techniques of pharmaceutical chemistry have revolutionized the design of drugs beyond previous expectations. But what are our current expectations and what does the future hold? Glaxo Wellcome has set itself the objective of introducing three significant new medicines a year, every year, by 2000.

    Collection
Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links